ArticleSpinal cord2026

Response to "Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims".

Hasan Ali AlsailawiPubMed ↗Publisher ↗

No numbers read from the abstract.